Clovis Oncology reported $-64982000 in EBIT for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -66772000 390K
Acceleron Pharma XLRN:US $ -63603000 6.01M
Acorda Therapeutics ACOR:US $ -26657000 6.16M
Agenus AGEN:US $ -41371000 16.23M
Agios Pharmaceuticals AGIO:US $ -91217000 1.22M
Anika Therapeutics ANIK:US $ -984000 5.08M
Arrowhead Research ARWR:US $ -28232000 4.18M
AstraZeneca AZN:LN 1.03B 425M
Astrazeneca AZN:US 1.03B 425M
Eli Lilly And LLY:US $ 1666.2M 662.1M
Enanta Pharmaceuticals ENTA:US $ -29700000 17.4M
Esperion Therapeutics ESPR:US $ -82824000 12.74M
GlaxoSmithKline GSK:LN 1.68B 59M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Halozyme Therapeutics HALO:US $ 50.74M 26.89M
Insmed INSM:US $ -83833000 10.7M
Intrexon XON:US $ -17688000 807K
Ligand Pharmaceuticals LGND:US $ 5.14M 11.04M
Merk MRK:US $ 4290M 4007M
Mirati Therapeutics MRTX:US $ -132421000 26.09M
Neurocrine Biosciences NBIX:US $ 31.5M 40.3M
Novartis NOVN:VX 2.99B 332M
Pfizer PFE:US $ 5757M 4605M
Puma Biotechnology PBYI:US $ 20.15M 31.3M
Rigel Pharmaceuticals RIGL:US $ 41.76M 60.58M
Sangamo Biosciences SGMO:US $ -46302000 2.87M
Seattle Genetics SGEN:US $ -122420000 287.41M
Ultragenyx Pharmaceutical RARE:US $ -106569000 10.49M
Veracyte VCYT:US $ -10315000 2.24M
YTE INCY:US $ 114.81M 65.45M